- Our Work
- Economic Growth and Trade
- Global Health
- Peace and Security
- Gender Equality and Female Empowerment
- Science, Technology, Innovation and Partnerships
- Being LGBT in Asia
- Lower Mekong Initiative (LMI)
- Reports and Publications
- Transforming Lives
- Partnership Opportunities
- Business Opportunities
Since 2003, USAID has supported HIV programming to understand and address the needs of key affected populations in Burma, China (the southern two provinces of Yunnan and Guangxi), Laos, Papua New Guinea, and Thailand. Through the U.S. President’s Emergency Plan for HIV/AIDS Relief (PEPFAR), USAID now partners with the U.S. Centers for Disease Control and Prevention to help countries throughout Southeast Asia lead the identification, evaluation, adoption and implementation of more impactful and cost-efficient approaches to address HIV and AIDS.
The goals of USAID’s regional HIV and AIDS program are to reduce the disease's impact and to reduce the cost of national responses to HIV and AIDS in the region. This is done through work with key at-risk populations like men who have sex with men, intravenous drug users and sex workers and their clients, as well as HIV-infected or affected individuals. Prevention efforts focus on reaching key affected populations and care and support efforts strive to efficiently bring high-quality services to beneficiaries regardless of location and enable them to lead full and productive lives.
HIV/AIDS regional program achievements in Burma, China, Laos, and Thailand for 2012 included:
- More than 107,000 people benefited from community outreach activities to prevent HIV by sharing information about safe health practices and services available at drop-in centers and health facilities.
- More than 13,800 individuals benefitted from innovative HIV testing and counseling services.
- USAID provided basic clinical care, tuberculosis/HIV care, and home- and community-based care to 14,531 HIV-infected or affected individuals.
- USAID supported the provision of antiretroviral therapy (the use of drugs to suppress the HIV virus and stop the progression of HIV disease) to 7,748 individuals.
- 626 local organizations received technical assistance (professional advice, training, scholarships, construction and commodities) to develop strategic information activities, HIV-related policy development, and HIV-related institutional capacity building.
Last updated: January 13, 2016